Pharma, health and science writer at Reuters. Any opinions are mine.
#Roche CEO tells us his $8B #InterMune acquisition not a signal for more big deals and he "happy" with #Chugai setup reut.rs/1tYVMtq
Now U.S. lawmakers call for curbs on #antibiotic use on farms reut.rs/1oW0Szx
#Switzerland takes on its top drugmakers in price row reut.rs/1u0Ijxp #pharma @carocopley
Betting on BACE inhibition --> #AstraZeneca to get up to $500M from #Lilly under #Alzheimer's drug partnership deal reut.rs/1yaavo5
Reuters Farmaceuticals: the drugs fed to farm animals and the risks posed to humans reuters.com/investigates/s… via @SpecialReports
#Gilead licenses #hepatitis C drug to 7 Indian firms reut.rs/1tVN6UG <--important news but will it ensure comprehensive access?
Another day, another deal ... #Danaher to buy #Nobel Biocare Holding for $2.2B, including debt reut.rs/1tVhTAV
RT @epaultaylor: Study suggests a cheaper alternative to a costly eye drug used to treat macular degeneration. By @reutersBenHir feeds.reuters.com/~r/reuters/hea…
New #European Commission boss #Juncker under fire for making medicines industrial, not health issue reut.rs/1xTigOV #pharma
BAT's novel #e-cigarette rival wins UK medical approval reut.rs/1oAiT6w $BATS
Create a free Muck Rack account to customize your profile and upload a portfolio of your
For instructions on how to pitch Ben Hirschler, email